Form D · Biotechnology
Celerpurus Inc
Durham, NC · CIK 0001858204
Offering snapshot reported Jan 12, 2022 · SEC filing
- Reported sold
- $150K Offering amount: $150K
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 7, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 12, 2022 | Initial | $150,000 | No comparison | 15 | SEC filing |
| Apr 26, 2021 | Initial | $375,000 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-429075
Source: Form D, filed Jan 12, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jay Corscadden | Director, Executive, Promoter |
| Jay Croscadden | Director, Executive, Promoter |
| Thomas Finegan | Director, Executive |
| Peter Menges | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2655 Meridian Pkwy
Durham, NC, 27612
Durham, NC, 27612